Products

Clopidogrel camphorsulfonate isanganiswa yemishonga ine kemikari formula C16H16ClNO2S·C10H16O4S.Iyo inowanzozivikanwa seClopidogrel S-oxide camphorsulfonate kana Clopidogrel CAMS.Mushonga uyu unobva ku chiral kubva ku clopidogrel, iyo inoshandiswa zvakanyanya antiplatelet mishonga.Kushandiswa kwekutanga kweClopidogrel camphorsulfonate sechinhu chinoshanda mukugadzira antiplatelet zvinodhaka.Inoshanda nekudzivisa kuunganidzwa kweplatelet, kudzivirira kuumbwa kweropa, uye kuderedza njodzi yezviitiko zvemoyo.Iyo kompani inonangana neP2Y12 receptor pamaplatelet, nekudaro ichivharira iyo activation process uye inhibiting platelet aggregation.Iyi nzira yekuita inoita kuti Clopidogrel camphorsulfonate ibudirire mukudzivirira arterial thrombosis uye kuderedza kuitika kwezviitiko zvakashata zvemwoyo, kusanganisira kurwisa kwemoyo uye sitiroko.Kana yangopinzwa, inoshandura metabolic muchiropa, zvichikonzera kuumbwa kweiyo inoshanda metabolite.Iyi metabolite inoshanda yobva yasunga zvisingachinjike kuP2Y12 receptor, ichishandisa antiplatelet yayo mhedzisiro kwenguva yakareba.Muchiitiko chekiriniki, Clopidogrel camphorsulfonate inowanzo kurongerwa varwere vane acute coronary syndromes, senge isina kugadzikana angina uye myocardial infarction, kana avo vakaita percutaneous coronary. kupindira (PCI) nekuisa stent.Inoshandiswawo zvakanyanya kudzivirira kuitika kwezviitiko zve thrombotic kune varwere vane nhoroondo yesitiroko kana peripheral artery disease.Kushandiswa kweClopidogrel camphorsulfonate kunowanzo kusanganiswa neashoma-dose aspirin kuti iwedzere antiplatelet therapy. Zvakakosha kuziva kuti Clopidogrel camphorsulfonate inofanira kushandiswa chete pasi pekutariswa kwenyanzvi yehutano, sezvo inogona kupindirana nemimwe mishonga kana kuve nekupikisa mune mamwe maitiro. varwere vakawanda.Chiyero uye nguva yekurapa inogona kusiyana zvichienderana nemamiriro ekurapa kwemunhu, uye kugara uchitarisisa kushanda kweplatelet uye kuongororwa ropa kungave kuri madikanwa kuti ive nechokwadi chekurapa kwakakwana. kunyanya avo vanosanganisira arterial thrombosis.Its antiplatelet properties uye yakasarudzwa inhibition yeP2Y12 receptor inoita kuti ive mushonga unoshanda wekuderedza njodzi yezviitiko zvakashata zvemwoyo.Nekudaro, sekunge chero musanganiswa wemishonga, kungwarira kunofanirwa kushandiswa mukushandiswa kwayo, uye varwere vanofanirwa kutevedzera kurudziro nenhungamiro yevanopa hutano.